58 research outputs found
Recommended from our members
Human platelet protein ubiquitylation and changes following GPVI activation
Platelet activators stimulate post-translational modification of signalling proteins to change their
activity or their molecular interactions leading to signal propagation. One covalent modification is attachment of the small protein ubiquitin to lysine residues in target proteins. Modification by ubiquitin can either target proteins for degradation by the proteasome or act as a scaffold for other proteins. Pharmacological inhibition of deubiquitylases or the proteasome inhibits platelet
activation by collagen, demonstrating a role for ubiquitylation, but relatively few substrates for
ubiquitin have been identified and the molecular basis of inhibition is not established. Here we report the ubiquitome of human platelets and changes in ubiquitylated proteins following stimulation by collagen related peptide (CRP-XL). Using platelets from six individuals over three
independent experiments, we identified 1634 ubiquitylated peptides derived from 691 proteins, revealing extensive ubiquitylation in resting platelets. 925 of these peptides show an increase of more than 2-fold following stimulation with CRP-XL. Multiple sites of ubiquitylation were 16 identified on a number of proteins including Syk, filamin and integrin heterodimer subunits. This work reveals extensive protein ubiquitylation during activation of human platelets and opens the possibility of novel therapeutic interventions targeting the ubiquitin machinery
Screening of DUB activity and specificity by MALDI-TOF mass spectrometry
Deubiquitylases (DUBs) are key regulators of the ubiquitin system which cleave ubiquitin moieties from proteins and polyubiquitin chains. Several DUBs have been implicated in various diseases and are attractive drug targets. We have developed a sensitive and fast assay to quantify in vitro DUB enzyme activity using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Unlike other current assays, this method uses unmodified substrates, such as diubiquitin topoisomers. By analyzing 42 human DUBs against all diubiquitin topoisomers we provide an extensive characterization of DUB activity and specificity. Our results confirm the high specificity of many members of the OTU and JAMM DUB families and highlight that all USPs tested display low linkage selectivity. We also demonstrate that this assay can be deployed to assess the potency and specificity of DUB inhibitors by profiling 11 compounds against a panel of 32 DUBs
Optimised oligonucleotide substrates to assay XPF ERCC1 nuclease activity for the discovery of DNA repair inhibitors
We report the design and optimisation of novel oligonucleotide substrates for a sensitive fluorescence assay for high-throughput screening and functional studies of the DNA repair enzyme, XPF-ERCC1, with a view to accelerating inhibitor and drug discover
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1.
The endogenous metabolite itaconate has recently emerged as a regulator of macrophage function, but its precise mechanism of action remains poorly understood. Here we show that itaconate is required for the activation of the anti-inflammatory transcription factor Nrf2 (also known as NFE2L2) by lipopolysaccharide in mouse and human macrophages. We find that itaconate directly modifies proteins via alkylation of cysteine residues. Itaconate alkylates cysteine residues 151, 257, 288, 273 and 297 on the protein KEAP1, enabling Nrf2 to increase the expression of downstream genes with anti-oxidant and anti-inflammatory capacities. The activation of Nrf2 is required for the anti-inflammatory action of itaconate. We describe the use of a new cell-permeable itaconate derivative, 4-octyl itaconate, which is protective against lipopolysaccharide-induced lethality in vivo and decreases cytokine production. We show that type I interferons boost the expression of Irg1 (also known as Acod1) and itaconate production. Furthermore, we find that itaconate production limits the type I interferon response, indicating a negative feedback loop that involves interferons and itaconate. Our findings demonstrate that itaconate is a crucial anti-inflammatory metabolite that acts via Nrf2 to limit inflammation and modulate type I interferons
Molecular basis of USP7 inhibition by selective small-molecule inhibitors
Ubiquitination controls the stability of most cellular proteins, and its deregulation contributes to human diseases including cancer. Deubiquitinases remove ubiquitin from proteins, and their inhibition can induce the degradation of selected proteins, potentially including otherwise 'undruggable' targets. For example, the inhibition of ubiquitin-specific protease 7 (USP7) results in the degradation of the oncogenic E3 ligase MDM2, and leads to re-activation of the tumour suppressor p53 in various cancers. Here we report that two compounds, FT671 and FT827, inhibit USP7 with high affinity and specificity in vitro and within human cells. Co-crystal structures reveal that both compounds target a dynamic pocket near the catalytic centre of the auto-inhibited apo form of USP7, which differs from other USP deubiquitinases. Consistent with USP7 target engagement in cells, FT671 destabilizes USP7 substrates including MDM2, increases levels of p53, and results in the transcription of p53 target genes, induction of the tumour suppressor p21, and inhibition of tumour growth in mice
Variant PRC1 Complex-Dependent H2A Ubiquitylation Drives PRC2 Recruitment and Polycomb Domain Formation
Chromatin modifying activities inherent to polycomb
repressive complexes PRC1 and PRC2 play an
essential role in gene regulation, cellular differentiation, and development. However, the mechanisms
by which these complexes recognize their target
sites and function together to form repressive chromatin domains remain poorly understood. Recruitment of PRC1 to target sites has been proposed to
occur through a hierarchical process, dependent
on prior nucleation of PRC2 and placement of
H3K27me3. Here, using a de novo targeting assay
in mouse embryonic stem cells we unexpectedly
discover that PRC1-dependent H2AK119ub1 leads
to recruitment of PRC2 and H3K27me3 to effectively
initiate a polycomb domain. This activity is restricted
to variant PRC1 complexes, and genetic ablation
experiments reveal that targeting of the variant
PCGF1/PRC1 complex by KDM2B to CpG islands is
required for normal polycomb domain formation
and mouse development. These observations provide a surprising PRC1-dependent logic for PRC2
occupancy at target sites in vivo.This study was funded by the Wellcome Trust (WT0834922 and WT081385), CRUK (C28585/A10839), NIHR, EMBO, Lister Institute of Preventative Medicine, RIKEN, MEXT, and JST CRES
Biochemical and mass spectrometry-based approaches to profile SUMOylation in human cells
Posttranslational modification of proteins with the small ubiquitin-like modifier (SUMO) regulates protein function in the context of cell cycle and DNA repair. The occurrence of SUMOylation is less frequent as compared to protein modification with ubiquitin, and appears to be controlled by a smaller pool of conjugating and deconjugating enzymes. Mass spectrometry has been instrumental in defining specific as well as proteome-wide views of SUMO-dependent biological processes, and several methodological approaches have been developed in the recent past. Here, we provide an overview of the latest experimental approaches to the study of SUMOylation, and also describe hands-on protocols using a combination of biochemistry and mass spectrometry-based technologies to profile proteins that are SUMOylated in human cells
“The club on the hill”: footballing place as an arena for sustainable and ethical action
Purpose
Places have deep-seated meaning and serve to shape our social grouping and practices. Sporting stadia are a highly influential aspect of many people’s lives that drive the inexorable journey towards team affiliation, immersive experiences, intense loyalty and the creation of an enduring, local identity. This paper aims to explore how the nature of a sporting place has been shaped to change the practice of football as a sport, as a business and as entertainment. This paper uncovers how Forest Green Rovers (FGR) differentiates itself from the historical and socio-economic roots of football and uses numerous novel sustainability initiatives to re-imagine a new type of football place, club and fandom.
Design/methodology/approach
Over a two-year period, the authors used multiple data collection methods, engaging in participant observation, interviews and focus groups, at FGR and related events. A thematic data analysis was conducted to pinpoint and extract key areas surrounding the unique structures, practices and reinforced behaviours that have developed in FGR.
Findings
The findings show that FGR’s place operates as a central location through which stakeholders, ideas, resources and practices have been disrupted and re-imagined around the principles of sustainability. This fundamental shift in FGR’s place, changing its composition, character and reach, means that FGR can be conceptualised as a novel place synonymous with new global social movements.
Originality/value
This study presents unique insights into the world’s first socially and environmentally conscious football club. This study examines the construction and operation of the place that facilitates its actions which go beyond what has been seen and maybe expected from commercial sporting institutions.
</jats:sec
- …